Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies

• 收藏
• 分享

专利权人:

Genentech, Inc.;Chugai Seiyaku Kabushiki Kaisha

发明人:

Endo, Mika,Kato, Atsuhiko,Ohtomo, Toshihiko,Adachi, Kenji,Kinoshita, Yasuko,Narita, Yoshinori

申请号：

AU2017235097

公开号：

AU2017235097A1

申请日:

2017.03.14

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The disclosure provides compositions and methods for treating cancers. The methods comprising administering a PD-1 axis binding antagonist and an anti-GPC3 antibody. The compositions comprising a pharmaceutical composition for treating cancer which comprises a PD-1 axis binding antagonist and an anti-GPC3 antibody. Also disclosed are a pharmaceutical composition to be used in combination with a PD-1 axis binding antagonist for treating cancer which comprises an anti-GPC3 antibody as the active ingredient； and a pharmaceutical composition to be used in combination with an anti-GPC3 antibody for treating cancer which comprises as the active ingredient a PD-1 axis binding antagonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/